Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA)

Historical Holders from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
ORKA on Nasdaq
Shares outstanding
49,592,111
Price per share
$30.33
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
45,557,409
Holdings value
$875,822,951
% of all portfolios
0%
Share change
+11,125,430
Value change
+$220,884,500
Average buys %
+0%
Average sells %
-0%
Number of holders
103
Price from insider filings
$29.75
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fairmount Funds Management LLC 20% 0% $161,971,372 +$38,464,806 11,162,741 +31% Fairmount Funds Management LLC 17 Sep 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% -11% $94,415,901 +$14,638,312 4,909,619 +18% Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025
VIKING GLOBAL INVESTORS LP 5.5% $38,693,672 2,666,690 VIKING GLOBAL INVESTORS LP 17 Sep 2025
BlackRock, Inc. 4.5% -16% $43,430,407 +$4,123,376 2,197,517 +10% BlackRock, Inc. 30 Sep 2025
RTW INVESTMENTS, LP 5.2% $18,328,014 1,945,649 RTW Investments, LP 31 Mar 2025
Deep Track Capital, LP 5.1% $17,867,668 1,896,780 Deep Track Capital, LP 06 May 2025
As of 30 Sep 2025, Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA) has 103 institutional shareholders filing 13F forms. They hold 45,557,409 shares of 49,592,111 outstanding shares (92%) .

Top 25 institutional shareholders own 85% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
FMR LLC 15% 7,257,621 +29% 0.01% $139,564,052
VR ADVISER, LLC 8.4% 4,148,428 0% 4.5% $79,774,270
Fairmount Funds Management LLC 7.5% 3,705,262 +9.9% 6.4% $71,252,188
VIKING GLOBAL INVESTORS LP 5.4% 2,666,690 0.13% $51,280,449
Deep Track Capital, LP 5.4% 2,654,781 +38% 1.4% $51,051,438
BlackRock, Inc. 4.4% 2,204,551 +11% 0% $42,393,516
RTW INVESTMENTS, LP 3.9% 1,945,649 0% 0.46% $37,414,830
VANGUARD GROUP INC 3.6% 1,776,665 -2.2% 0% $34,165,268
Commodore Capital LP 3.5% 1,753,054 +23% 1.6% $33,711,228
BRAIDWELL LP 2.8% 1,382,350 -9.3% 0.79% $26,582,591
Avoro Capital Advisors LLC 2.7% 1,333,340 0.33% $25,640,128
PERCEPTIVE ADVISORS LLC 2.6% 1,268,021 0.71% $24,384,044
FRANKLIN RESOURCES INC 2.1% 1,065,782 +5.2% 0.01% $20,494,988
Point72 Asset Management, L.P. 2.1% 1,037,002 +214% 0.04% $19,941,548
Polar Capital Holdings Plc 2.1% 1,032,307 +5.9% 0.1% $19,851,264
Affinity Asset Advisors, LLC 1.9% 959,180 +59% 1.7% $18,445,031
MERCER GLOBAL ADVISORS INC /ADV 1.7% 852,411 +0.01% 0.03% $16,391,864
Blackstone Inc. 1.7% 850,400 +2.9% 0.07% $16,353,192
GEODE CAPITAL MANAGEMENT, LLC 1.4% 689,972 -2.5% 0% $13,271,325
Avidity Partners Management LP 1.3% 660,424 +88% 2.9% $12,699,954
STATE STREET CORP 1.3% 652,028 +75% 0% $12,538,498
PRICE T ROWE ASSOCIATES INC /MD/ 1.3% 626,806 +53% 0% $12,054,000
Woodline Partners LP 1.2% 574,330 +47% 0.05% $11,044,366
Cormorant Asset Management, LP 1.1% 533,340 0.71% $10,256,128
Cable Car Capital, LP 1% 500,000 -17% 4.1% $9,615,000

Institutional Holders of Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 8,402 $254,850 +$254,061 $30.33 3
2025 Q3 45,557,409 $875,822,951 +$220,884,500 $19.23 103
2025 Q2 34,429,035 $385,950,468 +$30,431,124 $11.21 81
2025 Q1 31,776,517 $326,087,518 -$21,453,525 $10.26 70
2024 Q4 31,038,311 $606,624,310 +$125,781,786 $19.39 66
2024 Q3 24,559,501 $604,174,991 +$603,646,395 $24.51 42